Company intelligence / Profile preview

Leiber

Bramsche, Lower Saxony, Germanyjudithleiber.com ↗

Ownership: Private
Development stage: Other

Overview

Leiber is a global leader in the upcycling of brewers’ yeast into innovative products for human nutrition, animal health, biotechnology (including fermentation), and agriculture. The company’s yeast extracts improve the growth rate of microorganisms in industrial fermentations by providing assimilable nitrogen and micronutrients. It operates globally with five facilities across three countries and serves over 65 nations.

Modalities: Microbial therapy (via yeast extracts)Nutritional ingredient
Industry: Non-Drug Biotech

Partnerships

Asahi Group FoodsCollaborates with breweries worldwide for yeast sourcing/upcycling

Beyond the preview

Go deeper on Leiber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leiber.

Explore the full profile